Company / Shareholders' Equity
NEUROONE MEDICAL TECHNOLOGIES Corp Shareholders' Equity History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$822.0K
FY2025
5-year range
-$1.2M / $9.6M
FY2021-FY2025
Trend
-86.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 10 years, ranging from -$1M in FY2021 to $10M in FY2023.
Based on SEC 10-K filings.
$822,013 in FY2025 with a 3-year CAGR of -49.9%.
Declined from $10M to $822,013 over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -49.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -49.9%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 86.8% year-over-year.
- Peak shareholders' equity was recorded in FY2023.
- Lowest shareholders' equity in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $822.0K | -86.8% |
| FY2024 | $6.2M | -34.9% |
| FY2023 | $9.6M | +46.5% |
| FY2022 | $6.6M | +629.6% |
| FY2021 | -$1.2M | -988.9% |
| FY2016 | -$113.7K | -221.1% |
| FY2015 | -$35.4K | -16.8% |
| FY2014 | -$30.3K | -824.4% |
| FY2012 | -$3.3K | +24.2% |
| FY2011 | -$4.3K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026